Astec LifeSciences (NSE:ASTEC, BOM:533138) has received board approval to raise up to 2.50 billion Indian rupees through a rights issue of shares, according to a Tuesday filing with the Indian stock exchanges.
The board approved the issue of fully paid-up equity shares of the company of face value of 10 rupees each by way of a rights issue to the eligible equity shareholders of the company.
The record date for the issue will be decided later.
The company's shares were up over 7% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。